167 related articles for article (PubMed ID: 22274760)
1. Polymeric micelles of PEG-PE as carriers of all-trans retinoic acid for stability improvement.
Wichit A; Tangsumranjit A; Pitaksuteepong T; Waranuch N
AAPS PharmSciTech; 2012 Mar; 13(1):336-43. PubMed ID: 22274760
[TBL] [Abstract][Full Text] [Related]
2. N-phthaloylchitosan-g-mPEG design for all-trans retinoic acid-loaded polymeric micelles.
Opanasopit P; Ngawhirunpat T; Rojanarata T; Choochottiros C; Chirachanchai S
Eur J Pharm Sci; 2007 Apr; 30(5):424-31. PubMed ID: 17307343
[TBL] [Abstract][Full Text] [Related]
3. Polyion complex micelles composed of all-trans retinoic acid and poly (ethylene glycol)-grafted-chitosan.
Jeong YI; Kim SH; Jung TY; Kim IY; Kang SS; Jin YH; Ryu HH; Sun HS; Jin S; Kim KK; Ahn KY; Jung S
J Pharm Sci; 2006 Nov; 95(11):2348-60. PubMed ID: 16886178
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administration.
Kawakami S; Opanasopit P; Yokoyama M; Chansri N; Yamamoto T; Okano T; Yamashita F; Hashida M
J Pharm Sci; 2005 Dec; 94(12):2606-15. PubMed ID: 16258978
[TBL] [Abstract][Full Text] [Related]
5. Polymeric micelles: polyethylene glycol-phosphatidylethanolamine (PEG-PE)-based micelles as an example.
Sawant RR; Torchilin VP
Methods Mol Biol; 2010; 624():131-49. PubMed ID: 20217593
[TBL] [Abstract][Full Text] [Related]
6. Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer.
Tan BJ; Liu Y; Chang KL; Lim BK; Chiu GN
Int J Nanomedicine; 2012; 7():651-61. PubMed ID: 22334787
[TBL] [Abstract][Full Text] [Related]
7. PEG-PLA diblock copolymer micelle-like nanoparticles as all-trans-retinoic acid carrier: in vitro and in vivo characterizations.
Li Y; Qi XR; Maitani Y; Nagai T
Nanotechnology; 2009 Feb; 20(5):055106. PubMed ID: 19417337
[TBL] [Abstract][Full Text] [Related]
8. Critical determinant of intestinal permeability and oral bioavailability of pegylated all trans-retinoic acid prodrug-based nanomicelles: Chain length of poly (ethylene glycol) corona.
Li Z; Han X; Zhai Y; Lian H; Zhang D; Zhang W; Wang Y; He Z; Liu Z; Sun J
Colloids Surf B Biointerfaces; 2015 Jun; 130():133-40. PubMed ID: 25907597
[TBL] [Abstract][Full Text] [Related]
9. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan.
Emami J; Maghzi P; Hasanzadeh F; Sadeghi H; Mirian M; Rostami M
Pharm Dev Technol; 2018 Jan; 23(1):41-54. PubMed ID: 28608760
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs.
Sezgin Z; YĆ¼ksel N; Baykara T
Eur J Pharm Biopharm; 2006 Nov; 64(3):261-8. PubMed ID: 16884896
[TBL] [Abstract][Full Text] [Related]
11. Modified polyvinylalcohol for encapsulation of all-trans-retinoic acid in polymeric micelles.
Zuccari G; Carosio R; Fini A; Montaldo PG; Orienti I
J Control Release; 2005 Mar; 103(2):369-80. PubMed ID: 15763620
[TBL] [Abstract][Full Text] [Related]
12. Micellar complexes of all-trans retinoic acid with polyvinylalcohol-nicotinoyl esters as new parenteral formulations in neuroblastoma.
Zuccari G; Bergamante V; Carosio R; Gotti R; Montaldo PG; Orienti I
Drug Deliv; 2009 May; 16(4):189-95. PubMed ID: 19241235
[TBL] [Abstract][Full Text] [Related]
13. EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.
Ren H; Gao C; Zhou L; Liu M; Xie C; Lu W
Drug Deliv; 2015; 22(6):785-94. PubMed ID: 24670093
[TBL] [Abstract][Full Text] [Related]
14. Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles.
Sou K; Endo T; Takeoka S; Tsuchida E
Bioconjug Chem; 2000; 11(3):372-9. PubMed ID: 10821653
[TBL] [Abstract][Full Text] [Related]
15. Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations.
Sahib MN; Darwis Y; Peh KK; Abdulameer SA; Tan YT
Int J Nanomedicine; 2011; 6():2351-66. PubMed ID: 22072872
[TBL] [Abstract][Full Text] [Related]
16. Effects of polyethyleneglycol chain length and phospholipid acyl chain composition on the interaction of polyethyleneglycol-phospholipid conjugates with phospholipid: implications in liposomal drug delivery.
Bedu-Addo FK; Tang P; Xu Y; Huang L
Pharm Res; 1996 May; 13(5):710-7. PubMed ID: 8860425
[TBL] [Abstract][Full Text] [Related]
17. Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile.
Li W; Wu J; Zhang J; Wang J; Xiang D; Luo S; Li J; Liu X
Drug Deliv; 2018 Nov; 25(1):827-837. PubMed ID: 29587545
[TBL] [Abstract][Full Text] [Related]
18. Influence of histidine on the release of all-trans retinoic acid from self-assembled glycol chitosan nanoparticles.
Lee CM; Park JW; Kim J; Kim DW; Jeong HJ; Lee KY
Drug Dev Ind Pharm; 2010 Jul; 36(7):781-6. PubMed ID: 20136494
[TBL] [Abstract][Full Text] [Related]
19. Linear-dendritic copolymer composed of polyethylene glycol and all-trans-retinoic acid as drug delivery platform for paclitaxel against breast cancer.
Li J; Jiang X; Guo Y; An S; Kuang Y; Ma H; He X; Jiang C
Bioconjug Chem; 2015 Mar; 26(3):418-26. PubMed ID: 25675244
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and optimization of a novel polymeric micelle based on hyaluronic acid and phospholipids for delivery of paclitaxel, in vitro and in-vivo evaluation.
Saadat E; Amini M; Khoshayand MR; Dinarvand R; Dorkoosh FA
Int J Pharm; 2014 Nov; 475(1-2):163-73. PubMed ID: 25148729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]